モノクローナル抗体診断試薬の世界市場:検査別分析(酵素結合免疫吸着法、二重抗原サンドイッチ化学発光法、アッセイ組換えイムノブロット法、ドット免疫金濾過アッセイ法)、用途別分析(腫瘍モニタリング、ウイルス検出、ホルモン診断、その他)、地域別規模・予測(COVID-19の影響分析付き)、2028年までの予測Global Monoclonal Antibody Diagnostic Reagent Market: Analysis By Tests (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay), By Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028 モノクローナル抗体診断試薬は、モノクローナル抗体を活性成分として使用し、感染性病原体、異常細胞、または病気に対する身体の反応の一部を同定する試薬である。2022年、世界のモノクローナル抗体診断試薬市場... もっと見る
サマリーモノクローナル抗体診断試薬は、モノクローナル抗体を活性成分として使用し、感染性病原体、異常細胞、または病気に対する身体の反応の一部を同定する試薬である。2022年、世界のモノクローナル抗体診断試薬市場は88.5億米ドルと評価され、2028年には186.3億米ドルに達する見込みである。また、がん、自己免疫疾患、感染症など幅広い疾患の治療薬として、モノクローナル抗体治療薬の強力なパイプラインが開発されていることから、市場は今後さらに拡大すると予想される。さらに、モノクローナル抗体の合成と精製において著しい技術進歩が見られる。これにより、モノクローナル抗体診断試薬のコストと入手性が低下し、その用途も広がっている。モノクローナル抗体診断試薬の世界市場価値は、2023-2028年の予測期間中にCAGR 13.25%で成長すると予測されている。 市場細分化分析: 検査別報告書によると、世界のモノクローナル抗体診断試薬市場は4つの検査に区分される:酵素結合免疫吸着法(Enzyme Linked Immunosorbent)、二重抗原サンドイッチ化学発光法(Double Antigen Sandwich Chemiluminescence Method)、アッセイ組換えイムノブロット法(Assay Recombinant Immunoblot)、ドット免疫金濾過法(Dot-immunogold Filtration Assay)である。酵素結合免疫吸着法(Enzyme Linked Immunosorbent)は、生物学的サンプル中の特定のタンパク質、抗体、抗原、その他の化合物を同定するための一般的な生化学的手法であるため、2022年の市場シェアの大半を占めている。一方、同分野のCAGRが最も速いのは、がん、感染症、自己免疫疾患などの慢性疾患の有病率の増加によるもので、これらはELISA検査を使って診断・モニタリングできる。 用途別:報告書によると、世界のモノクローナル抗体診断試薬市場は4つの用途に区分される:腫瘍モニタリング、ウイルス検出、ホルモン診断、その他である。腫瘍マーカーを検出し、腫瘍を画像化し、腫瘍を標的として治療を行うことができるため、腫瘍モニタリング分野は2022年に市場の大半のシェアを獲得した。これは、がんの診断、治療、モニタリングの改善に役立つ。一方、ウイルス検出分野のCAGRが最も速いのは、モノクローナル抗体が標的抗原に対して特異性が高いため、ごく少量の抗原を検出するのに使用できるからである。ウイルスはしばしば体内で低レベルに存在するため、これはウイルス検出にとって重要である。 地域別本レポートでは、モノクローナル抗体診断試薬市場を地域別(北米、欧州、アジア太平洋地域、その他の地域)に分析している。北米のモノクローナル抗体診断試薬市場は、2022年に最も高い市場シェアを獲得した。これは、企業による研究開発費の増加や、政府によるがん研究への資金援助により、革新的なモノクローナル抗体治療法の開発が促進されたためである。 米国は、世界的に見ても最も医療支出が多い国のひとつである。このような医療インフラへの多額の投資が、モノクローナル抗体ベースの診断試薬を含む先進的な診断技術の採用を後押ししている。 さらに、アジア太平洋地域のモノクローナル抗体診断試薬は、同地域の政府や民間団体が医療に多額の投資を行っていることから、最も速いCAGRで成長すると予想されている。このため、新しい診断施設の開発や、モノクローナル抗体診断試薬のような新技術の採用が進んでいる。 モノクローナル抗体診断試薬の世界市場ダイナミクス: 成長の促進要因モノクローナル抗体診断試薬は、多くの癌の早期発見と正確な診断に役立つ。早期発見は、タイムリーな介入と救命治療の可能性を可能にするため、極めて重要である。モノクローナル抗体は特に、血液、組織、尿などの患者サンプルに含まれる癌関連抗原やバイオマーカーを標的とするように設計されている。さらに、高齢化、可処分所得の増加、医療費の増加、バイオテクノロジー企業への投資の増加、新規治療法を開発するための広範な研究開発努力などにより、市場の拡大が見込まれている。 課題市場の拡大は高コストによって阻害されると予測される。この価格設定の障壁は、アクセシビリティ、手頃な価格、持続可能性など、モノクローナル抗体ベースの診断薬の多くの分野に影響を及ぼす。モノクローナル抗体診断試薬は、一般的に他のタイプの診断試薬よりも高価である。モノクローナル抗体診断試薬市場が直面するその他の課題には、入手可能性の制限などがある。 トレンド世界のモノクローナル抗体診断試薬市場で見られる最も明確で広範なトレンドの1つは、ポイントオブケア検査(POCT)の利用可能性が高まっていることである。ポイント・オブ・ケア検査(POCT)により、診察室や診療所などの医療現場で患者を検査することが可能になる。これは患者にとって便利であり、患者の転帰を改善するのに役立つ。モノクローナル抗体診断試薬はPOCTアプリケーションに適しています。POCTはモノクローナル抗体診断試薬市場の重要なトレンドとして浮上している。予測期間中、モノクローナル抗体診断試薬市場のさらなる成長が見込まれるトレンドとしては、多重アッセイの利用拡大、技術進歩、モノクローナル抗体を用いた新しい治療法の開発などが挙げられる。 COVID-19の影響分析と今後の展望: COVID-19の流行は、モノクローナル抗体診断試薬の発見、製造、使用に大きな影響を与えたため、世界市場にプラスの影響を与えた。COVID-19用にいくつかのモノクローナル抗体診断試薬が開発されている。これらの試薬は臨床試験で使用されており、近い将来、広く使用できるようになると期待されている。パンデミックによって、モノクローナル抗体診断試薬の研究開発への資金も増加している。COVID-19が市場に与える影響は長期に及ぶと思われる。 競争環境と最近の動向: 世界のモノクローナル抗体診断試薬市場は断片化されている。世界のモノクローナル抗体診断試薬市場の主要プレーヤーは以下の通り: ベクトン・ディッキンソン・アンド・カンパニー(BDバイオサイエンス) メルク社 キアゲン バイオ・ラッド・ラボラトリーズ アブカム社(バイオビジョン) イノベント・バイオロジクス社 セルトリオン社 ユーロジェンテック(アナスペック) バイオジェネックス バイオケアメディカルLLC アビバ・システム・バイオロジー メディックス・バイオケミカ クリエイティブ・ダイアグノスティックス セル・シグナル・テクノロジー 主要企業は、この市場での競争力を維持するために、新製品の発売や新興市場への製品導入など、戦略的な取り組みに絶えず投資している。例えば、2022年1月、小野薬品工業株式会社(以下「小野薬品」という。神経変性疾患の新規治療標的に対するmAb医薬品の開発でNeuroimmune AGと提携した。 目次1. Executive Summary2. Introduction 2.1 Monoclonal Antibody Diagnostic Reagent: An Overview 2.1.1 Monoclonal Antibodies Used To Treat 2.2 Monoclonal Antibody Diagnostic Reagent Segmentation: An Overview 2.2.1 Monoclonal Antibody Diagnostic Reagent Segmentation 3. Global Market Analysis 3.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Analysis 3.1.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Overview 3.1.2 Global Monoclonal Antibody Diagnostic Reagent Market by Value 3.1.3 Global Monoclonal Antibody Diagnostic Reagent Market by Test (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay) 3.1.4 Global Monoclonal Antibody Diagnostic Reagent Market by Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others) 3.1.5 Global Monoclonal Antibody Diagnostic Reagent Market by Region (North America, Europe, Asia Pacific and Rest of the World) 3.2 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Analysis 3.2.1 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Overview 3.2.2 Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value 3.2.3 Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value 3.2.4 Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value 3.2.5 Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value 3.3 Global Monoclonal Antibody Diagnostic Reagent Market: Application Analysis 3.3.1 Global Monoclonal Antibody Diagnostic Reagent Market: Application Overview 3.3.2 Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value 3.3.3 Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value 3.3.4 Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value 3.3.5 Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value 4. Regional Market Analysis 4.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.1.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.1.2 North America Monoclonal Antibody Diagnostic Reagent Market by Value 4.1.3 North America Monoclonal Antibody Diagnostic Reagent Market by Region (The US, Canada and Mexico) 4.1.4 The US Monoclonal Antibody Diagnostic Reagent Market by Value 4.1.5 Canada Monoclonal Antibody Diagnostic Reagent Market by Value 4.1.6 Mexico Monoclonal Antibody Diagnostic Reagent Market by Value 4.2 Europe Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.2.1 Europe Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.2.2 Europe Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.3 Europe Monoclonal Antibody Diagnostic Reagent Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe) 4.2.4 Germany Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.5 UK Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.6 France Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.7 Italy Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.8 Spain Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.9 Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value 4.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.3.1 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.3.2 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific) 4.3.4 China Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.5 Japan Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.6 India Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.7 South Korea Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.8 Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value 4.4 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.4.1 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.4.2 Rest the World Monoclonal Antibody Diagnostic Reagent Market by Value 5. Impact of COVID-19 5.1 Impact of COVID-19 5.1.1 Impact of COVID-19 on Monoclonal Antibody Diagnostic Reagent 5.1.2 Post COVID-19 Impact 6. Market Dynamics 6.1 Growth Driver 6.1.1 Escalating Incidence of New Cancer Cases 6.1.2 Aging Population 6.1.3 Amplified Disposable Income 6.1.4 Growing Healthcare Expenditure 6.1.5 Growth in Investments in Biotech Companies 6.1.6 Extensive R&D Efforts to Develop Novel Therapies 6.2 Challenges 6.2.1 High Cost 6.2.2 Limited Availability 6.3 Market Trends 6.3.1 Increasing Availability of Point-of-care Testing (POCT) 6.3.2 Growing Use of Multiplexed Assays 6.3.3 Technological Advancements 6.3.4 Development Of New Monoclonal Antibody-based Therapies 7. Competitive Landscape 7.1 Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison 8. Company Profiles 8.1 Becton, Dickinson and Company (BD Biosciences) 8.1.1 Business Overview 8.1.2 Operating Segments 8.1.3 Business Strategy 8.2 Merck & Co., Inc. 8.2.1 Business Overview 8.2.2 Operating Segments 8.2.3 Business Strategies 8.3 Qiagen 8.3.1 Business Overview 8.3.2 Operating Regions 8.3.3 Business Strategy 8.4 Bio-Rad Laboratories, Inc. 8.4.1 Business Overview 8.4.2 Operating Segments 8.4.3 Business Strategy 8.5 Abcam Plc., (BioVision) 8.5.1 Business Overview 8.5.2 Operating Regions 8.5.3 Business Strategy 8.6 Innovent Biologics, Inc. 8.6.1 Business Overview 8.6.2 Operating Regions 8.6.3 Business Strategy 8.7 Celltrion, Inc. 8.7.1 Business Overview 8.7.2 Operating Segments 8.8 Eurogentec (AnaSpec) 8.8.1 Business Overview 8.8.2 Business Strategy 8.9 BioGenex 8.9.1 Business Overview 8.9.2 Business Strategy 8.10 Biocare Medical LLC 8.10.1 Business Overview 8.10.2 Business Strategy 8.11 Aviva Systems Biology 8.11.1 Business Overview 8.11.2 Business Strategy 8.12 Medix Biochemica 8.12.1 Business Overview 8.12.2 Business Strategy 8.13 Creative Diagnostics 8.13.1 Business Overview 8.14 Cell Signaling Technology 8.14.1 Business Overview List of Figures Figure 1: Monoclonal Antibodies Used To Treat Figure 2: Monoclonal Antibody Diagnostic Reagent Segmentation Figure 3: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 4: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 5: Global Monoclonal Antibody Diagnostic Reagent Market by Test; 2022 (Percentage, %) Figure 6: Global Monoclonal Antibody Diagnostic Reagent Market by Application; 2022 (Percentage, %) Figure 7: Global Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 8: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 9: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 10: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 11: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 12: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 13: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 14: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 15: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 16: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 17: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 18: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 19: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 20: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 21: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 22: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 23: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 24: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 25: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 26: North America Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 27: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 28: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 29: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 30: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 31: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 32: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 33: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 34: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 35: Europe Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 36: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 37: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 38: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 39: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 40: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 41: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 42: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 43: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 44: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 45: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 46: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 47: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 48: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 49: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 50: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 51: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 52: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 53: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 54: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 55: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 56: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 57: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 58: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 59: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 60: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 61: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 62: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 63: The US Estimated Numbers of New Cancer Cases; 2017-2023 (Million) Figure 64: Global Percentage of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %) Figure 65: Global GNI per Capita; 2016-2022 (Thousand) Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %) Figure 67: Becton, Dickinson and Company Revenue by Segment; 2022 (Percentage, %) Figure 68: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %) Figure 69: Qiagen Net Sales by Regions; 2022 (Percentage, %) Figure 70: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2022 (Percentage, %) Figure 71: Abcam Plc. Revenue by Regions; 2022 (Percentage, %) Figure 72: Innovent Biologics, Inc. Revenue by Regions; 2022 (Percentage, %) Figure 73: Celltrion, Inc. Revenue by Segments; 2022 (Percentage, %) Table 1: Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison; 2023
SummaryMonoclonal Antibody Diagnostic Reagents are reagents that use monoclonal antibodies as active components to identify infectious pathogens, aberrant cells, or parts of the body's reaction to sickness. In 2022, the global monoclonal antibody diagnostic reagent market was valued at US$8.85 billion, and is probable to reach US$18.63 billion by 2028. Table of Contents1. Executive Summary2. Introduction 2.1 Monoclonal Antibody Diagnostic Reagent: An Overview 2.1.1 Monoclonal Antibodies Used To Treat 2.2 Monoclonal Antibody Diagnostic Reagent Segmentation: An Overview 2.2.1 Monoclonal Antibody Diagnostic Reagent Segmentation 3. Global Market Analysis 3.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Analysis 3.1.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Overview 3.1.2 Global Monoclonal Antibody Diagnostic Reagent Market by Value 3.1.3 Global Monoclonal Antibody Diagnostic Reagent Market by Test (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay) 3.1.4 Global Monoclonal Antibody Diagnostic Reagent Market by Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others) 3.1.5 Global Monoclonal Antibody Diagnostic Reagent Market by Region (North America, Europe, Asia Pacific and Rest of the World) 3.2 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Analysis 3.2.1 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Overview 3.2.2 Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value 3.2.3 Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value 3.2.4 Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value 3.2.5 Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value 3.3 Global Monoclonal Antibody Diagnostic Reagent Market: Application Analysis 3.3.1 Global Monoclonal Antibody Diagnostic Reagent Market: Application Overview 3.3.2 Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value 3.3.3 Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value 3.3.4 Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value 3.3.5 Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value 4. Regional Market Analysis 4.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.1.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.1.2 North America Monoclonal Antibody Diagnostic Reagent Market by Value 4.1.3 North America Monoclonal Antibody Diagnostic Reagent Market by Region (The US, Canada and Mexico) 4.1.4 The US Monoclonal Antibody Diagnostic Reagent Market by Value 4.1.5 Canada Monoclonal Antibody Diagnostic Reagent Market by Value 4.1.6 Mexico Monoclonal Antibody Diagnostic Reagent Market by Value 4.2 Europe Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.2.1 Europe Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.2.2 Europe Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.3 Europe Monoclonal Antibody Diagnostic Reagent Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe) 4.2.4 Germany Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.5 UK Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.6 France Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.7 Italy Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.8 Spain Monoclonal Antibody Diagnostic Reagent Market by Value 4.2.9 Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value 4.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.3.1 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.3.2 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific) 4.3.4 China Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.5 Japan Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.6 India Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.7 South Korea Monoclonal Antibody Diagnostic Reagent Market by Value 4.3.8 Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value 4.4 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Analysis 4.4.1 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Overview 4.4.2 Rest the World Monoclonal Antibody Diagnostic Reagent Market by Value 5. Impact of COVID-19 5.1 Impact of COVID-19 5.1.1 Impact of COVID-19 on Monoclonal Antibody Diagnostic Reagent 5.1.2 Post COVID-19 Impact 6. Market Dynamics 6.1 Growth Driver 6.1.1 Escalating Incidence of New Cancer Cases 6.1.2 Aging Population 6.1.3 Amplified Disposable Income 6.1.4 Growing Healthcare Expenditure 6.1.5 Growth in Investments in Biotech Companies 6.1.6 Extensive R&D Efforts to Develop Novel Therapies 6.2 Challenges 6.2.1 High Cost 6.2.2 Limited Availability 6.3 Market Trends 6.3.1 Increasing Availability of Point-of-care Testing (POCT) 6.3.2 Growing Use of Multiplexed Assays 6.3.3 Technological Advancements 6.3.4 Development Of New Monoclonal Antibody-based Therapies 7. Competitive Landscape 7.1 Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison 8. Company Profiles 8.1 Becton, Dickinson and Company (BD Biosciences) 8.1.1 Business Overview 8.1.2 Operating Segments 8.1.3 Business Strategy 8.2 Merck & Co., Inc. 8.2.1 Business Overview 8.2.2 Operating Segments 8.2.3 Business Strategies 8.3 Qiagen 8.3.1 Business Overview 8.3.2 Operating Regions 8.3.3 Business Strategy 8.4 Bio-Rad Laboratories, Inc. 8.4.1 Business Overview 8.4.2 Operating Segments 8.4.3 Business Strategy 8.5 Abcam Plc., (BioVision) 8.5.1 Business Overview 8.5.2 Operating Regions 8.5.3 Business Strategy 8.6 Innovent Biologics, Inc. 8.6.1 Business Overview 8.6.2 Operating Regions 8.6.3 Business Strategy 8.7 Celltrion, Inc. 8.7.1 Business Overview 8.7.2 Operating Segments 8.8 Eurogentec (AnaSpec) 8.8.1 Business Overview 8.8.2 Business Strategy 8.9 BioGenex 8.9.1 Business Overview 8.9.2 Business Strategy 8.10 Biocare Medical LLC 8.10.1 Business Overview 8.10.2 Business Strategy 8.11 Aviva Systems Biology 8.11.1 Business Overview 8.11.2 Business Strategy 8.12 Medix Biochemica 8.12.1 Business Overview 8.12.2 Business Strategy 8.13 Creative Diagnostics 8.13.1 Business Overview 8.14 Cell Signaling Technology 8.14.1 Business Overview List of Figures Figure 1: Monoclonal Antibodies Used To Treat Figure 2: Monoclonal Antibody Diagnostic Reagent Segmentation Figure 3: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 4: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 5: Global Monoclonal Antibody Diagnostic Reagent Market by Test; 2022 (Percentage, %) Figure 6: Global Monoclonal Antibody Diagnostic Reagent Market by Application; 2022 (Percentage, %) Figure 7: Global Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 8: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 9: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 10: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 11: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 12: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 13: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 14: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 15: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 16: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 17: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 18: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 19: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 20: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 21: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 22: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 23: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 24: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 25: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 26: North America Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 27: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 28: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 29: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 30: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 31: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 32: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 33: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 34: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 35: Europe Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 36: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 37: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 38: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 39: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 40: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 41: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 42: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 43: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 44: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 45: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 46: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 47: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 48: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion) Figure 49: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 50: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %) Figure 51: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 52: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 53: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 54: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 55: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 56: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 57: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 58: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million) Figure 59: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 60: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 61: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million) Figure 62: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion) Figure 63: The US Estimated Numbers of New Cancer Cases; 2017-2023 (Million) Figure 64: Global Percentage of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %) Figure 65: Global GNI per Capita; 2016-2022 (Thousand) Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %) Figure 67: Becton, Dickinson and Company Revenue by Segment; 2022 (Percentage, %) Figure 68: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %) Figure 69: Qiagen Net Sales by Regions; 2022 (Percentage, %) Figure 70: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2022 (Percentage, %) Figure 71: Abcam Plc. Revenue by Regions; 2022 (Percentage, %) Figure 72: Innovent Biologics, Inc. Revenue by Regions; 2022 (Percentage, %) Figure 73: Celltrion, Inc. Revenue by Segments; 2022 (Percentage, %) Table 1: Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison; 2023
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Daedal Research 社の最新刊レポート
本レポートと同じKEY WORD(antibody)の最新刊レポート
よくあるご質問Daedal Research社はどのような調査会社ですか?デダルリサーチ (Daedal Research) はインドとアジアを始めとして世界の医療や医薬、ICT、エネルギー、通信、化学、交通、消費財などの様々な市場を調査対象とした市場調査報告書を出版してい... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/11 10:26 149.62 円 164.03 円 198.16 円 |